David Cluck, PharmD, BCPS, AAHIVP

home / authors / david-cluck-pharmd-bcps-aahivp

Articles

Site Logo

Guidelines to Caring for Patients With Sepsis: Promise or Progress?

Jessica Burchette, PharmD, BCPS;David Cluck, PharmD, BCPS, AAHIVP
August 8th 2017

Care continues to improve; however, drug-resistant pathogens and a lack of new agents to treat these infections remain a constant challenge.

Read More

Site Logo

Risks Associated With Direct-Acting Antivirals—Smoke or Fire?

Desirae Lindquist, PharmD, BCPS;David Cluck, PharmD, BCPS, AAHIVP
May 9th 2017

Should clinicians be extra vigilant when deciding who receives antiviral therapy, or are the adverse effects few and infrequent?

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
With the Rise of COVID-19 Vaccines, a Greater Public Mistrust of Immunizations Has Taken Hold
Published: March 25th 2025 | Updated: April 3rd 2025
With the Rise of COVID-19 Vaccines, a Greater Public Mistrust of Immunizations Has Taken Hold
FDA Approves Gepotidacin (Blujepa) for Uncomplicated Urinary Tract Infections
Published: March 25th 2025 | Updated: April 3rd 2025
FDA Approves Gepotidacin (Blujepa) for Uncomplicated Urinary Tract Infections
How a Prodrug Approach May Aid In Antimalarial Development
Published: March 21st 2025 | Updated: April 3rd 2025
How a Prodrug Approach May Aid In Antimalarial Development
Large Hospital System Experiences Significant Increases in Candida auris
Published: March 21st 2025 | Updated: April 3rd 2025
Large Hospital System Experiences Significant Increases in Candida auris
Immunocore Reports Some PWH Achieve Viral Control and Dose-Dependent Active HIV Reservoir Reduction in IMC-M113V Trial
Published: March 17th 2025 | Updated: April 3rd 2025
Immunocore Reports Some PWH Achieve Viral Control and Dose-Dependent Active HIV Reservoir Reduction in IMC-M113V Trial
© 2025 MJH Life Sciences

All rights reserved.